Pär-Ola Bendahl
201 – 210 of 236
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
High tumor tissue concentration of urokinase plasminogen activator receptor is associated with good prognosis in patients with ovarian cancer
- Contribution to journal › Article
-
Mark
Improved DNA flow cytometric, DNA ploidy, and S-phase reproducibility between 15 laboratories in analysis of breast cancer using generalized guidelines
- Contribution to journal › Article
-
Mark
Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.
- Contribution to journal › Article
-
Mark
Estrogen and progesterone receptor assay in paraffin-embedded breast cancer--reproducibility of assessment.
- Contribution to journal › Article
-
Mark
Comparison of immunohistochemical and biochemical assay of steroid receptors in primary breast cancer - Clinical associations and reasons for discrepancies
- Contribution to journal › Article
- 2002
-
Mark
Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis
- Contribution to journal › Article
-
Mark
TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer
- Contribution to journal › Article
-
Mark
High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer.
- Contribution to journal › Article
-
Mark
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 8377 breast cancer patients
- Contribution to journal › Article
-
Mark
Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas.
- Contribution to journal › Article